xuelian huang
University of Washington
Seattle, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
University of Washington
Seattle, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
Northeastern University
Shenyang, China
Review Editor
Pharmacology of Anti-Cancer Drugs
China Medical University Hospital
Taichung, Taiwan
Review Editor
Pharmacology of Anti-Cancer Drugs
Chia Nan University of Pharmacy and Science
Tainan, Taiwan
Review Editor
Pharmacology of Anti-Cancer Drugs
Stanford University
Stanford, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
Center for Precision Health, School of Biomedical Informatics, University of Texas Health Science Center at Houston
Houston, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
University of Copenhagen
Copenhagen, Denmark
Review Editor
Pharmacology of Anti-Cancer Drugs
Pfizer
New York, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
Gifu University Hospital
Gifu, Japan
Review Editor
Pharmacology of Anti-Cancer Drugs
COMSATS University Islamabad, Abbottabad Campus
Abbottabad, Pakistan
Review Editor
Pharmacology of Anti-Cancer Drugs
Federal University of Alfenas
Alfenas, Brazil
Review Editor
Pharmacology of Anti-Cancer Drugs
Institut National de la Santé et de la Recherche Médicale (INSERM)
Paris, France
Review Editor
Pharmacology of Anti-Cancer Drugs
McGill University
Montreal, Canada
Review Editor
Pharmacology of Anti-Cancer Drugs
Central University of Punjab
Bathinda, India
Review Editor
Pharmacology of Anti-Cancer Drugs
Daegu Haany University
Gyeongsan, Republic of Korea
Review Editor
Pharmacology of Anti-Cancer Drugs
Swiss Federal Institute of Technology Lausanne
Lausanne, Switzerland
Review Editor
Pharmacology of Anti-Cancer Drugs